News & Perspective

Oct 28, 2010

Oct 28, 2010

First clinical trial results for norovirus vaccine outlined

(CIDRAP News) – In the first clinical trial of a norovirus vaccine—in which volunteers were deliberately exposed to the common gastrointestinal virus—the inoculation reduced participants' risk of illness by 47%, according to results released recently by LigoCyte Pharmaceuticals, Inc.